- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- Science Education Progress
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Generally Lackluster R&D Funding
Various outlets are lamenting the cuts and paltry increases to Federal science funding in the omnibus spending package passed by Congress and headed for the President’s desk. Among chief concerns is that the funding increase for several agencies—including the NIH, which receives the lion’s share of R&D dollars—will not keep pace with the predicted rate of inflation. AAAS calculates that over all, “Federal funding for basic and applied research would decline in real terms for the fourth year in a row.”
The most notable increase is for DOE energy R&D focused on carbon sequestration, biomass, and solar energy, as this graph, adapted from the AAAS demonstrates:
SOURCE: AAAS R&D Budget and Policy Program
While this does demonstrate federal support for an energy policy that leads to a lower-carbon economy, experts have called for more substantial support, including doubling the R&D budget for energy research.
The omnibus package retains language mandating that NIH-funded research be made publicly available for free within 12 months of publication.
But as we have mentioned previously, the perennial focus within science policy discussions on “how much” monetary support science receives from the Federal government cannot preclude questions of “what for.” There are legitimate values questions associated with how the government allocates funding for scientific research and who the potential beneficiaries of that research are. An equitable distribution of science funding will ultimately support both curiosity-driven discovery and innovation that lead to a more equitable and dynamic economy and a safer, healthier country.
Comments on this article


